SPR206 acetate

SPR206 acetate Suppliers list
Company Name: BOC Sciences  
Tel: +1-631-485-4226
Email: inquiry@bocsci.com
Company Name: ChemeGen(Shanghai) Biotechnology Co.,Ltd.  
Tel: 18818260767
Email: sales@chemegen.com
Company Name: Guangzhou Younan Technology Co., Ltd  
Tel: 020-82000279 18988941452
Email: YN_research@163.com
Company Name: Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.  
Tel: 025-025-66113011 15955137747
Email: cb5@aikonchem.com
Company Name: Zhejiang Huida Biotech Co., Ltd.  
Tel: 0571-89903022 18679456698
Email: zilong@hizyme.com
SPR206 acetate Basic information
Product Name:SPR206 acetate
Synonyms:SPR206 acetate
CAS:2408422-41-1
MF:C54H86ClN15O14
MW:1204.82
EINECS:
Product Categories:
Mol File:2408422-41-1.mol
SPR206 acetate Structure
SPR206 acetate Chemical Properties
form Solid
color White to off-white
Safety Information
MSDS Information
SPR206 acetate Usage And Synthesis
UsesSPR206 acetate is a polymyxin analog with antibiotic activity against Gram-negative pathogens, including multidrug-resistant (MDR) variants. SPR206 acetate has an anti-bacterial infection effect by interacting with the bacterium’s outer membrane. The MIC values of SPR206 acetate against Pseudomonas aeruginosa Pa14 and Acinetobacter baumannii NCTC13301 are both 0.125 mg/L[1][2].
in vivo

SPR206 (0.125-30 mg/kg; intravenous injection or subcutaneous injection; every 8 hours or every 4 hours; for 16 hours or 24 hours; neutropenic mice) treatment reduces the burden of Pa14 and NCTC13301 in lung tissue and in the thigh model[2].

Animal Model:Neutropenic mice infected Pa14 or NCTC13301[2]
Dosage:3 mg/kg, 10 mg/kg, 20 mg/kg, 30 mg/kg (intravenous injection); 0.125 mg/kg, 0.5 mg/kg, 1 mg/kg, 4 mg/kg (subcutaneous injection)
Administration:Intravenous injection or subcutaneous injection; every 8 hours or every 4 hours; for 16 hours or 24 hours
Result:In lung tissue, reduced the burden of Pa14 and NCTC13301 by 1.5 and 3.6 log10 CFU/mL. In the thigh model, reduced the burden of Ab13301 by 3.4 and 4.3 log10 CFU/g.
References[1] Brown P, et al. Design of Next Generation Polymyxins with Lower Toxicity: The Discovery of SPR206. ACS Infect Dis. 2019 Oct 11;5(10):1645-1656. DOI:10.1021/acsinfecdis.9b00217
[2] L. Grosser, et al. In Vivo Efficacy of SPR206 in Murine Lung and Thigh Infection Models Caused by Multidrug Resistant Pathogens Pseudomonas aeruginosa and Acinetobacter baumanii. Poster-139 ASM ESCMID 2018 Lisbon, Portugal.
[3] Noushin Akhoundsadegh, et al. Outer Membrane Interaction Kinetics of New Polymyxin B Analogs in Gram-Negative Bacilli. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00935-19. DOI:10.1128/AAC.00935-19
SPR206 acetate Preparation Products And Raw materials
Tag:SPR206 acetate(2408422-41-1) Related Product Information
Doxorubicin hydrochloride Rapamycin Carbonyl cyanide 3-chlorophenylhydrazone Brefeldin A Adenosine triphosphate β-Estradiol